 |
Finsbury is handling press for Reckitt Benckiser Group, which yanked its $20B deal on March 21 to acquire Pfizer's consumer healthcare business.
CEO Rakesh Kapoor decided that Pfizer's consumer health business wasn't a good fit, opting instead to concentrate on the $16B integration of Mead Johnson's nutritional formula business and the reorganizing of operations into health and hygiene business units.
GlaxoSmithKline today said it also has decided not to pursue the acquisition of Pfizer's consumer healthcare unit.
“While we will continue to review opportunities that may accelerate our strategy, they must meet our criteria for returns and not compromise our priorities for capital allocation,” said CEO Emma Walmsley in a statement.
Pfizer is reviewing its strategic alternatives, which could mean sale, spin-off or retaining the consumer operation.
Jenn Kettnich, who has more than 15 years of financial communications experience, has joined Liftoff Mobile as VP-investor relations following completion of its recent IPO.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
